Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP177116.RADmJy856Kd6o5z51C_GieLXSg3w5R_unsEv6wrVUrlKU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP177116.RADmJy856Kd6o5z51C_GieLXSg3w5R_unsEv6wrVUrlKU130_assertion type Assertion NP177116.RADmJy856Kd6o5z51C_GieLXSg3w5R_unsEv6wrVUrlKU130_head.
- NP177116.RADmJy856Kd6o5z51C_GieLXSg3w5R_unsEv6wrVUrlKU130_assertion description "[Median survival of RA and RARS patients was 67.9 months and significantly longer than that of CMML, RAEB, or RAEB-T patients with median survivals of 16.1, 16.8, and 9.5 months, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP177116.RADmJy856Kd6o5z51C_GieLXSg3w5R_unsEv6wrVUrlKU130_provenance.
- NP177116.RADmJy856Kd6o5z51C_GieLXSg3w5R_unsEv6wrVUrlKU130_assertion evidence source_evidence_literature NP177116.RADmJy856Kd6o5z51C_GieLXSg3w5R_unsEv6wrVUrlKU130_provenance.
- NP177116.RADmJy856Kd6o5z51C_GieLXSg3w5R_unsEv6wrVUrlKU130_assertion SIO_000772 9172814 NP177116.RADmJy856Kd6o5z51C_GieLXSg3w5R_unsEv6wrVUrlKU130_provenance.
- NP177116.RADmJy856Kd6o5z51C_GieLXSg3w5R_unsEv6wrVUrlKU130_assertion wasDerivedFrom befree-20140225 NP177116.RADmJy856Kd6o5z51C_GieLXSg3w5R_unsEv6wrVUrlKU130_provenance.
- NP177116.RADmJy856Kd6o5z51C_GieLXSg3w5R_unsEv6wrVUrlKU130_assertion wasGeneratedBy ECO_0000203 NP177116.RADmJy856Kd6o5z51C_GieLXSg3w5R_unsEv6wrVUrlKU130_provenance.